Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Texas City Chemicals, Inc.

(Site Profile/Docket Number 112)

Location: Texas City, Texas

Also known as: American Oil Co., Borden, Inc., Smith-Douglass, Amoco Chemical Company

Special Exposure Cohort Petition Information

The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 "specified cancers," and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.

Open/Active SEC Petitions

To date, there are no open/active SEC petitions from Texas City Chemicals, Inc..

Class(es) Added to the SEC

  • All Atomic Weapons Employer employees who worked at Texas City Chemicals, Inc., from October 5, 1953, through September 30, 1955, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.

    Note: This class was established from Petition 88

SEC Petitions Not Qualifying for Evaluation

There was one additional petition received but it did not qualify for evaluation. The petition did not meet the minimum petition requirements for evaluation.

Petitions Qualified for Evaluation

Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.

Petitions

Petition 88Jan 1, 1952 to Dec 31, 1956

Petition 88
Steps in Petition Process: Petition Details:

Date Received

March 13, 2007

Date Qualified for Evaluation

August 17, 2007

Summary of Information in Petition

Location: Texas City, Texas

Job Titles and/or Job Duties: All employees

Period of Employment: January 1, 1952 through December 31, 1956

Note: The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.

Copy of the Petition Received

March 13, 2007 [551 KB (10 pages)]

Federal Register Notice Announcing that a Mallinckrodt Chemical Co., Destrehan St. Plant SEC Petition has met the Minimum Qualifications for Review and Evaluation

August 28, 2007 [41 KB (1 page)]

SEC Petition Evaluation Report

Revised October 19, 2010 [450 KB (64 pages)]

Evaluation Report Sent to the Advisory Board

February 1, 2008

Petition Discussed by the Advisory Board

The Advisory Board discussed the petition on November 17, 2010, April 7, 2008, and June 26, 2008, during its regular meetings.

Advisory Board Recommendation on SEC Petition

December 8, 2010 [33 KB (2 pages)] (October 5, 1953, through September 30, 1955)

HHS Letters to Congress Regarding the SEC Petition

January 6, 2011 [75 KB (9 pages)] (October 5, 1953, through September 30, 1955)

HHS Designation of Additional Members to the SEC

January 6, 2011 [33 KB (4 pages)] (October 5, 1953, through September 30, 1955)

Federal Register Notice: Designation Regarding a Class of Employees for Addition to the Special Exposure Cohort

January 21, 2011 [41 KB (1 page)] (October 5, 1953, through September 30, 1955)

Effective Date for the SEC Class

February 5, 2011

Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort

February 11, 2011 [49 KB (1 page)] (October 5, 1953, through September 30, 1955)

Letter to DOL Regarding the Addition of a New Class of Employees to the SEC

February 7, 2011 [18 KB (1 page)] (October 5, 1953, through September 30, 1955)

Worker Outreach Activities

Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.

At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.

Below are the Worker Outreach Activities for the Texas City Chemicals, Inc.:

  • November 15, 2007

    Town Hall Meeting on Texas City Chemicals, Inc. Captain's Room of the Nessler Center 2010 5th Avenue North Texas City, Texas

    7:00 p.m. to 9:00 p.m.

    Former workers, as well as family members, are invited and encouraged to attend.

    Purpose: This meeting is an opportunity for former workers, and their families, to hear about NIOSH's responsibilities under Part B of EEOICPA, including its dose reconstruction program and the SEC petition process. Please note this meeting is not an opportunity to discuss individual claim status; however, representatives from NIOSH and the Department of Labor will be available to answer general questions related to EEOICPA.

    Minutes [38 KB (8 pages)]

  • October 18, 2007

    Meeting with former workers International Union of Operating Engineers Local 564 hall Texas City, Texas

    Final Minutes

Advisory Board Work Group on Texas City Chemicals, Inc.

This Work Group will consider the conditions under which "surrogate" data can be used as a valid substitute for actual data for a given site. The Work Group will seek to establish the type and importance of various parameters (e.g., type of nuclide, amounts of material, chemical and physical forms, processes, working conditions, and other such parameters) that impact on worker dose, and will consider the extent to which such parameters at one site may apply to other sites. The Work Group may also consider the extent to which theoretical considerations can be properly used to bound dosed in the absence of actual workplace measurements. The Work Group should strive to develop a policy recommendation that can be adopted by the Board regarding the use of surrogate data. This Work Group was asked to consider the application of surrogate data criteria to the Texas City Chemicals, Inc., site in relation to the SEC petition for that facility.

Work Group Members:

  • James Malcolm Melius, M.D., Dr. P.H. (Chair)
  • Josie Beach
  • Mark Griffon
  • James E. Lockey, M.D., M.S.
  • Wanda I. Munn

Meeting Information:

  • November 5, 2010 Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data

    Time/Location:

    1:00 p.m. Eastern Standard Time (EST)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

  • May 13, 2010 Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data

    Time/Location:

    1:00 p.m. Eastern Standard Time (EST)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

  • January 11, 2010 Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data

    1:00 p.m. Eastern Standard Time (EST)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

  • May 8, 2009 Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data

    Time/Location:

    1:00 p.m. Eastern Standard Time (EST)
    Meeting Type: Teleconference; Public, No Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

  • June 9, 2008 Teleconference Meeting of the Advisory Board's Work Group on Surrogate Data

    Time/Location:

    11:30 a.m. Eastern Standard Time (EST)
    Meeting type: Teleconference; Open to Public; No Public Comment Period

    Teleconference: +1-866-659-0537
    Participant Code: 9933701

    Available Meeting Items:

Advisory Board and NIOSH Comments and Discussion Papers on Texas City Chemicals, Inc.

The Texas City Chemicals, Inc. discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.

The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.

Public Comments on Texas City Chemicals, Inc. Documents

How to Submit Comments

Comments on Texas City Chemicals, Inc. Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:

NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226

Please include the Site Profile/Docket Number (112) on all comments.

Comments Received

Document Archive for Texas City Chemicals, Inc.

 
Contact DCAS:
Contact Us:
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO